ENDRA Life Sciences
NDRA
2 hedge funds and large institutions have $191K invested in ENDRA Life Sciences in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
56% more capital invested
Capital invested by funds: $122K → $191K (+$68.8K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MOS
MGO One Seven
Beachwood,
Ohio
|
+$114K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MOS
1
MGO One Seven
Beachwood,
Ohio
| $67K | +$114K | +1 | New |
|
|
WEC
2
Winslow Evans & Crocker
Boston,
Massachusetts
| $52K | – | – | – |
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $40K | – | – | – |
|
|
IFAM
4
Institutional & Family Asset Management
Fort Collins,
Colorado
| $26K | – | – | – |
|
5
UBS Group
Zurich,
Switzerland
| $6K | – | – | – |
|
NDRA Hedge Fund Activity: Q1 2018 in Review
2 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q1 2018, worth a combined $191K — up 56% from $122K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new NDRA positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was MGO One Seven, opening a new position worth an estimated $114K.
- 2 institutional investors held ENDRA Life Sciences (NDRA) as of Q1 2018, up from 1 in Q4 2017.
- Funds reported $191K of ENDRA Life Sciences stock for Q1 2018, up 56% quarter-over-quarter.
- 1 fund opened new ENDRA Life Sciences positions in Q1 2018 and 0 closed out, a net change of +1 holder.
- The largest ENDRA Life Sciences buyer in Q1 2018 was MGO One Seven, an estimated $114K added.
Based on aggregated 13F filings for Q1 2018.